Rheumatic heart disease (RHD) is a common cardiac problem. Medical therapy is directed toward secondary prophylaxis and supportive treatment for heart failure (HF), rhythm disorder and anticoagulation to prevent thromboembolism. Drug utilization patterns thus provide a favorable feedback to physicians and help to modify treatment strategies.
of RHD 10.2 per thousand indicating that population prevalence of RHD increases when echocardiography is used for screening [5] . RHD is one of the common types of structural heart disease and carry a significant morbidity and mortality in developing countries. Medical therapy in RHD includes measures to prevent RF and thus RHD. In patients who develop RHD, therapy is directed toward eliminating the group A streptococcal pharyngitis, suppressing inflammation and providing supportive treatment for HF, rhythm disorder and anticoagulation in selected cases to prevent thromboembolism. Periodic evaluation of drug use patterns in hospital setting can be of help to monitor and supervise the drug use behaviors. Drug utilization studies thus provide a favorable feedback to treating physicians and help to modify treatment strategies, identify and correct the shortcomings if any, thus providing a rational and cost effective therapy to the patients. This study was conducted in patients with RHD to highlight these facts.
Material and Methods
This was a descriptive cross-sectional study conducted from October 2017 to September 2018. The diagnosis of RHD was made on the basis of clinical history, examination and echocardiography. A total of 140 patients of RHD were enrolled consecutively who received care at cardiology clinic of Nobel Medical College Teaching Hospital. A semi structured questionnaire was administered to record the demographic characteristics, comorbid conditions and use of different drugs. Physical examination was performed to note vital signs and abnormal cardiac and neurological findings. Electrocardiography and echocardiography were done to define electrical and structural heart abnormalities respectively. Biochemical parameters were requested to look for blood hemoglobin, renal function and INR if clinically indicated. Collected data were entered in microsoft excel. Mean, standard deviation and IQR (Interquartile range) were calculated for descriptive statistics. Tabular presentation was be made where necessary.
Results
Mean age was 50.09 (range 22-80) years. The number of RHD was more in females (75.7%) as compared to males (24.2%). Among all patients, 10 (7.1%) were current smoker and 9 (6.4%) were significant alcohol consumer. Mean hemoglobin (Hb) was 12.5 ± 2.02 gm/dl. Mean body mass index (BMI) was 21.42 ± 3.98 kg/m 2 . Mean estimated glomerular filtration rate (eGFR) was 69.48 ± 19.8 ml/min with majority 121 (86.4%) had reduced eGFR of <90 ml/min. Table 1 shows baseline characteristics of the study population. Penicillin prophylaxis was prescribed for 38 (27.1%) patients. Out of which, 22.8% were on daily oral penicillin and 4.2% were receiving three weekly intramuscular injection of benzathine benzylpenicillin. Beta blockers were the most frequently used drug for heart rate control for patients (51.4%) with both AF and/or symptomatic moderate to severe mitral stenosis. Digoxin was used in 10% and calcium channel blockers were used in 3.5% of patients who had AF. Different diuretic agents were used in 88.5% of patients who had clinical features of systemic or pulmonary congestion. Out of 20 cases of AF, three (15%) had evidence of stroke. Eleven (55%) were receiving aspirin and nine (45%) patients were on warfarin for prevention of stroke and thromboembolism. Out of nine patients receiving warfarin, only four (20%) had therapeutic INR at the time of enrollment. Mitral valve was the most commonly affected valve (82.1%) followed by aortic valve (10%). Both mitral and aortic valves were involved in 7.8 % patients. Primary TV was involved in 2.8% and secondary TR was present in 52.1% cases. 
Discussion
RHD is a significant complication of RF. Although, RF is equally common in both males and females, RHD tends to be more common in females [6, 7] . In our study, female cases of RHD (75.7%) were more compared to males. It is unclear whether this difference in RHD prevalence is due to greater susceptibility to autoimmune responses following S. pyogenes infection or other social factors [8] . People who have suffered RF are more likely to have recurrent episodes and may cause further damage to the cardiac valves. Thus, RHD steadily worsens in people who have multiple episodes of ARF [9] . Primary Prevention is defined as treatment of group A streptococcal sore throat [10] and is indicated only when there is evidence of group A streptococcal infection [11] . Secondary prophylaxis is indicated to patients with a previous attack of RF or documented RHD. The purpose is to prevent colonization or infection of throat with group A beta-hemolytic streptococci and development of recurrence of RF. In our study, secondary prophylaxis was given in only 27.1% of cases. Although intramuscular injection of benzathine benzylpenicillin every three weeks is advised as the most effective therapy for prevention of recurrent attacks of RF [9] , only 4.2% of our patients were receiving benzathine benzylpenicillin. There are a number of interrelated factors associated with underutilization of secondary prophylaxis. RHD remain more prevalent in underprivileged settings. Poor access to health care facility, lack of family support, fear of anaphylaxis, need for long term painful injection etc. could be some reasons for low adherence of treatment and underutilization [11] . The most common cardiac manifestations of RHD are MS followed by aortic valve involvement [12] . In our patients, 82.1% had mitral valve involvement followed by aortic valve (10%) involvement either in the form of regurgitation or stenosis. MS is a slow and progressive condition, takes over decades, usually manifesting in the third to sixth decade of life [13] . Over time, decrease in stroke volume can cause reflex tachycardia which may contribute to an elevated left atrial pressure. The onset of AF secondary to the stenosis may precipitate acute pulmonary edema. The only medical therapies indicated for these patients are secondary prevention of repeat carditis [14] . Beta blockers can be helpful for symptomatic patients who have tachycardia and /or AF [15] . In our study, 51.4% patients of moderate to severe MS with or without AF were on beta blocker therapy. Medical management for RHD is provided based on the presence or absence of cardiac symptoms. Most patients with mild to moderate valvular disease remain asymptomatic for years. There is no role for medical therapy in patients with severe mitral or aortic regurgitation and preserved LV function [16] . Patients who are symptomatic or have decreased LV function should be referred for surgery. If surgical intervention is unavailable or contraindicated, medical therapy for systolic dysfunction is considered a reasonable course of treatment to manage symptoms. Diuretics are used judiciously in patients with evidence of systemic or pulmonary congestion. Anticoagulants should be administered in the setting of AF or LA thrombus or prior embolic event [15] . In our study, out of 20 cases of MS with AF, 45% patients were on oral anticoagulants and only 20% achieved therapeutic INR at the time of enrollment indicating marked underuse of anticoagulation. A study done in rural part of Nepal showed the marked underuse of anticoagulants, only 22.7% patients with RHD and AF obtained oral anticoagulants [17] . The reasons for under-treatment could be due to include lack of knowledge about treatment guidelines, perceived potential contraindications, fear of bleeding, poor drug compliance, cost and inconvenience of monitoring. Balloon valvuloplasty is performed if the valve anatomy is favorable and there is no significant mitral regurgitation [15] . Patients who have non-calcified, relatively mobile valves and lack severe leaflet thickening or subvalvular pathology are most likey to have good early and late outcome [18] .
Conclusions
The progression of RHD, beginning with S. pyogenes infection followed by RF and subsequent cardiac valve damage offers opportunities for the prevention. Improvement in the use of secondary prophylaxis may halt the progression of disease. This study focuses on prescription pattern of drugs for different indications in patients with RHD. There is a need for improved use of secondary prophylaxis to prevent recurrence of RF and anticoagulants for prevention of stroke in patients with AF.
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